Breast cancer survivors’ typhoid vaccine responses: Chemotherapy, obesity, and fitness make a difference
Janice K. Kiecolt‐Glaser(The Ohio State University), Rebecca Andridge(The Ohio State University), Robert Wesolowski(The Ohio State University Wexner Medical Center), Nicole Williams(The Ohio State University), Jeffrey VanDeusen(The Ohio State University), John F. Sheridan(The Ohio State University Wexner Medical Center), Bhuvaneswari Ramaswamy(The Ohio State University), Mathew Cherian(The Ohio State University Wexner Medical Center), William B. Malarkey(Institute for Behavioral Medicine), Raquel E. Reinbolt(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Juan Peng(Central South University), Daniel G. Stover(The Ohio State University), Anne M. Noonan(The Ohio State University), Sagar Sardesai(The Ohio State University), Megan E. Renna(The Ohio State University)
Cited by 14
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Inflammation: Depression Fans the Flames and Feasts on the Heat
|American Journal of Psychiatry|2015|846
Differences in Breast Cancer Survival by Molecular Subtypes in the United States
|Cancer Epidemiology Biomarkers & Prevention|2018|604
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
|Molecular Biology Reports|2020|576